Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.

Literature DB >> 30361243

Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.

Cécile Rotenberg^1,2, Valérie Besnard^3,2, Pierre-Yves Brillet⁴, Stéphane Giraudier⁵, Hilario Nunes^1,3, Dominique Valeyre^1,3.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 30361243 DOI： 10.1183/13993003.01482-2018

Source DB: PubMed Journal: Eur Respir J ISSN： 0903-1936 Impact factor: 16.671

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.

Authors: William Damsky; Durga Thakral; Meaghan K McGeary; Jonathan Leventhal; Anjela Galan; Brett King
Journal: J Am Acad Dermatol Date: 2019-06-08 Impact factor: 11.527

2. Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis.

Authors: Florence Jeny; Jean-François Bernaudin; Dominique Valeyre; Marianne Kambouchner; Marina Pretolani; Hilario Nunes; Carole Planès; Valérie Besnard
Journal: Front Immunol Date: 2021-08-11 Impact factor: 7.561

3. Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.

Authors: Carmen Álvarez-Reguera; Diana Prieto-Peña; Alba Herrero-Morant; Lara Sánchez-Bilbao; José Luis Martín-Varillas; Elena González-López; María Gutiérrez-Larrañaga; David San Segundo; Rosalía Demetrio-Pablo; Gonzalo Ocejo-Vinyals; Miguel A González-Gay; Ricardo Blanco
Journal: Ther Adv Musculoskelet Dis Date: 2022-04-29 Impact factor: 3.625

Review 4. Refractory Sarcoidosis: A Review.

Authors: Thomas El Jammal; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Dominique Valeyre; Pascal Sève
Journal: Ther Clin Risk Manag Date: 2020-04-17 Impact factor: 2.423

Review 9. The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.

Authors: Alice Wang; Katelyn Singh; Wael Ibrahim; Brett King; William Damsky
Journal: Yale J Biol Med Date: 2020-03-27

10. Treatment of granuloma annulare with tofacitinib 2% ointment.

Authors: William Damsky; Brett A King
Journal: JAAD Case Rep Date: 2019-12-30

Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.

1. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.

2. Hypoxia Promotes a Mixed Inflammatory-Fibrotic Macrophages Phenotype in Active Sarcoidosis.

3. Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.

Review 4. Refractory Sarcoidosis: A Review.

5. Treatment of Multiorgan Sarcoidosis With Tofacitinib.

6. Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid.

Review 7. Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.

Review 8. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Review 9. The Promise of JAK Inhibitors for Treatment of Sarcoidosis and Other Inflammatory Disorders with Macrophage Activation: A Review of the Literature.

10. Treatment of granuloma annulare with tofacitinib 2% ointment.